$0
0
0.00%
$40.3
Baillie Gifford started to build up the position in Cytokinetics in Q2 2022. Since then they sold 340 shares. The investor sold all their shares in Q2 2023 and doesn't own any shares in Cytokinetics anymore.
Easily embed the chart on your blog or website – it will always update automatically!